Obamacare May Have Helped Extend Lives of Young Cancer Patients guampdn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from guampdn.com Daily Mail and Mail on Sunday newspapers.
Obamacare May Have Helped Extend Lives of Young Cancer Patients independentnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from independentnews.com Daily Mail and Mail on Sunday newspapers.
Adding brentuximab vedotin to chemotherapy in pediatric Hodgkin lymphoma produced results that have been hailed as a paradigm shift and have just led to FDA approval for this new indication.
FDA approves Seagen's Adcetris combination for paediatric patients with Hodgkin lymphoma pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
A targeted therapy for children with high-risk Hodgkin lymphoma (HL) was shown to significantly reduce relapse rates when tested in a large multicenter clinical trial conducted by the Children's Oncology Group (COG) and led by pediatric oncologists at Roswell Park Comprehensive Cancer Center, Children's Healthcare of Atlanta and Winship Cancer Institute of Emory University. By combining the targeted antibody-drug conjugate (ADC) brentuximab vedotin (BV) with the standard chemotherapy regimen, children were 10% less likely to relapse.